oleuropein aglycone hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

oleuropein aglycone hamilelikte güvenli mi?

No harmonised CLP classification or SCCS/CIR safety assessment identifying reproductive toxicity for oleuropein aglycone or oleuropein; peer‑reviewed literature reports biological activity (neuroprotective, anti‑inflammatory) but not human teratogenicity or harmonised reproductive hazard. Dermal/topical use is expected to give low but measurable exposure. Sources: ECHA substance/C&L information (no harmonised CLP), PubMed reviews/studies. ([echa.europa.eu](https://echa.europa.eu/mt/substance-information/-/substanceinfo/100.228.865?utm_source=openai))

oleuropein aglycone emzirirken güvenli mi?

No authoritative classification or clinical data indicating reproductive/developmental hazard via lactation. Lack of data on transfer into human milk; by default topical cosmetic use implies low but measurable maternal systemic exposure and therefore low exposure to breastmilk. No CIR/SCCS or harmonised flags found. ([echa.europa.eu](https://echa.europa.eu/mt/substance-information/-/substanceinfo/100.228.865?utm_source=openai))

oleuropein aglycone bebek cildi için güvenli mi?

No infant‑specific reproductive/safety data found and no harmonised classification. Given measurable dermal absorption in adults (low), infant skin exposure (0–3 yr) has higher exposure potential (immature barrier, higher surface‑area/weight), so exposure score increased by +1. No evidence necessitating increased hazard or mechanism scores. ([echa.europa.eu](https://echa.europa.eu/mt/substance-information/-/substanceinfo/100.228.865?utm_source=openai))

VeriMom oleuropein aglycone nasıl puanlıyor?

VeriMom oleuropein aglycone'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.

Hamilelikte oleuropein aglycone yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.